Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Older men with lower levels of available testosterone are more likely to be frail.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Androgens may block hair growth signals, targeting this could treat hair loss.

Testosterone is crucial for development, growth, and various body functions in mammals.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Early balding at 40 increases prostate cancer risk.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Finasteride slowly binds to 5-alpha-reductase, affecting enzyme stability and inhibitor potency.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Certain gene variations might be linked to severe acne in women but not in men.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Certain drugs that block specific enzymes can help treat prostate diseases.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Alternative treatments show promise for hair growth beyond traditional methods.

Hsc70 protein may influence hair growth by responding to androgens.

XIST RNA helps regenerate hair follicles by targeting miR-424 and activating hedgehog signaling.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.